Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, if he will consider a de-linked model for biomedical research and development.

The Department is currently in discussion with the Association of the British Pharmaceutical Industry on models that delink company revenues from usage in the context of pricing of antibiotics.